Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 000100593 approvals101 trials

YUHAN CORPORATION

Official website

Founded in 1926 and listed on the KOSPI in 1962, Yuhan Corporation is a comprehensive pharmaceutical company known for its innovative drug Leclaza.

Price

Change

Market cap

Products & technology

  • LeclazaInnovative new drug
  • Antiphlamine
  • Bacom-C
  • Duowell
  • Copp Syrup
  • Elena

Regulatory approvals

data.go.kr

406 Korean MFDS drug approvals · 1960–2026 / 187 Korean MFDS device approvals · 1999–2022

  • MFDS drugLixieban Tablet 60mg(Edoxaban tosylate hydrate)2026-07-27
    Drug · Prescription · Approval202602154
  • MFDS drugLixieban tablet 30mg(Edoxaban tosylate hydrate)2026-07-27
    Drug · Prescription · Approval202602155
  • MFDS drugLixieban Tablet 15mg(Edoxaban tosylate hydrate)2026-07-27
    Drug · Prescription · Approval202602156
  • MFDS drugAntiphlamine-A Lotion2026-07-10
    Drug · OTC · Notification202602009
  • MFDS drugRapicol Power Cold Soft Capsule2026-07-09
    Drug · OTC · Notification202601992
  • MFDS drugRapicol Power Cough Soft Capsule2026-07-02
    Drug · OTC · Notification202601925
  • MFDS drugRapicol Power Nose Soft Capsule2026-06-09
    Drug · OTC · Notification202601624
  • MFDS drugYuhan Vono Tablet 20mg(Vonoprazanfumarate)2026-05-12
    Drug · Prescription · Approval202601373
  • MFDS drugYuhan Vono Tablet 10mg(Vonoprazanfumarate2026-05-12
    Drug · Prescription · Approval202601374
  • MFDS drugMicaclo Tablet 40/6.25mg2026-03-05
    Drug · Prescription · Approval202600659
  • MFDS drugMicaclo Tablet 40/12.5mg2026-03-05
    Drug · Prescription · Approval202600660
  • MFDS drugRabepid Tablet 20/600mg2026-02-10
    Drug · Prescription · Approval202600357
Show 68 more
  • MFDS drugRabepid Tablet 10/600mg2026-02-10
    Drug · Prescription · Approval202600358
  • MFDS drugRapico Nasalspray Solution2026-01-28
    Drug · OTC · Notification202600241
  • MFDS drugMelavely Cream2025-12-24
    Drug · OTC · Notification202503383
  • MFDS drugYuhan Pitavano Tablet 2/145mg2025-12-17
    Drug · Prescription · Approval202503295
  • MFDS drugTwinlow Tablet 20/2.5mg2025-12-08
    Drug · Prescription · Approval202503205
  • MFDS drugTruvita-S Tablet2025-11-25
    Drug · OTC · Notification202503064
  • MFDS drugTruset Tablet 20/2.5/6.25mg2025-09-30
    Drug · Prescription · Approval202502587
  • MFDS drugContac Cold Capsule2025-08-06
    Drug · OTC · Notification202502051
  • MFDS drugYuhan M-met XR Tablet 25/1000mg2025-07-29
    Drug · Prescription · Approval202501954
  • MFDS drugTraduoempaXR10/5/1000mg(empagliflozin, linagliptin, metformin)2025-07-29
    Drug · Prescription · Approval202501955
  • MFDS drugTraduoempaXR25/5/1000mg(empagliflozin, linagliptin, metformin)2025-07-29
    Drug · Prescription · Approval202501956
  • MFDS drugYuhan Minoxpen Gel 5%(Minoxidil)2025-07-15
    Drug · OTC · Notification202501797
  • MFDS drugAntiphlamine Cool Gel2025-06-27
    Drug · OTC · Notification202501608
  • MFDS drugYuhan M-met XR tablet 10/1000mg2025-06-23
    Drug · Prescription · Approval202501542
  • MFDS drugYuhan Acetaminophen Injection2025-06-19
    Drug · Prescription · Approval202501526
  • MFDS drugAntiphlamine Coin Alpha Plaster2025-06-18
    Drug · OTC · Notification202501506
  • MFDS drugRapicol Care Dry Syrup2025-05-28
    Drug · OTC · Notification202501326
  • MFDS drugYuhan Megavita Solution2025-03-19
    Drug · OTC · Notification202500628
  • MFDS drugCircle Green Tablet 240mg(Ginkgo leaf dry extract)2025-02-12
    Drug · OTC · Notification202500306
  • MFDS drugCariforman Soft Capsule(Cucurbit Semen Oil Extract(15~25->1))2025-01-08
    Drug · OTC · Notification202500072
  • MFDS drugXareba Tablet 13.5mg2024-12-23
    Drug · Prescription · Approval202403068
  • MFDS drugXareba Tablet 18mg2024-12-23
    Drug · Prescription · Approval202403069
  • MFDS drugMag-B EX Soft Capsule2024-07-29
    Drug · OTC · Notification202401818
  • MFDS drugMovana Tablet 0.2mg(Dutasteride)2024-07-25
    Drug · Prescription · Approval202401805
  • MFDS drugANTIPHLAMINE BIGPOWER PLASTER2024-06-14
    Drug · OTC · Notification202401447
  • MFDS drugMegatrue Six-Three-Three tablet2024-05-02
    Drug · OTC · Notification202401096
  • MFDS drugTraduoXR Tablet 5/1000mg(Linagliptin, Metformin hydrochloride)2024-03-29
    Drug · Prescription · Approval202400691
  • MFDS drugAntiphlamine 40 Plaster2024-02-14
    Drug · OTC · Notification202400324
  • MFDS drugAtorvamibe A Tablet 10/20/5mg2024-02-13
    Drug · Prescription · Approval202400309
  • MFDS drugAtorvamibe A Tablet 10/20/10mg2024-02-13
    Drug · Prescription · Approval202400310
  • MFDS drugAtorvamibe A Tablet 10/40/10mg2024-02-13
    Drug · Prescription · Approval202400311
  • MFDS drugAtovamibe A Tablet 10/10/5mg2024-01-12
    Drug · Prescription · Approval202400095
  • MFDS drugAtovamibe A Tablet 10/10/10mg2024-01-12
    Drug · Prescription · Approval202400096
  • MFDS drugAtovamibe Tablet 10/5mg(Ezetimibe, Atorvastatin calcium trihydrate)2023-05-26
    Drug · Prescription · Approval202301683
  • MFDS drugAtova Tablet 5mg(Atorvastatin calcium trihydrate)2023-05-18
    Drug · Prescription · Approval202301595
  • MFDS drugMinevita V Tab.2023-04-14
    Drug · OTC · Notification202301243
  • MFDS drugYuhan Edoxaban Tablet 30mg(Edoxaban besilate hydrate)2023-04-12
    Drug · Prescription · Approval202301207
  • MFDS drugYuhan Edoxaban Tablet 15mg(Edoxaban besilate hydrate)2023-04-12
    Drug · Prescription · Approval202301208
  • MFDS drugRosuvamibe10/2.5mg(Ezetimibe, Rosuvastatin calcium)2023-02-07
    Drug · Prescription · Approval202300468
  • MFDS drugYuhan Acetaminophen Tablet 500mg2023-02-02
    Drug · OTC · Notification202300437
  • MFDS drugYuhan Pregabalin SR tablet 75mg2022-12-30
    Drug · Prescription · Approval202204702
  • MFDS drugMag-B Speed Double Action Solution2022-12-28
    Drug · OTC · Notification202204680
  • MFDS drugYuhan Edoxaban Tablet 60mg(Edoxaban besilate hydrate)2022-12-05
    Drug · Prescription · Approval202204361
  • MFDS drugYuhan Cetirizine Tablet2022-11-02
    Drug · OTC · Notification202203978
  • MFDS drugRAPICOL COLD SOFTCAPSULES2022-07-20
    Drug · OTC · Notification202203017
  • MFDS drugYuhan Evefen Soft Capsule2022-06-10
    Drug · OTC · Notification202202422
  • MFDS drugDuowell A Plus Tablet 80/5/10/5mg2022-05-20
    Drug · Prescription · Approval202202135
  • MFDS drugDuowell A Plus Tablet 80/20/10/5mg2022-05-20
    Drug · Prescription · Approval202202136
  • MFDS drugDuowell A Plus Tabelt 80/10/10/5mg2022-05-20
    Drug · Prescription · Approval202202137
  • MFDS drugDuowell A Plus Tablet 40/5/10/5mg2022-05-20
    Drug · Prescription · Approval202202138
  • MFDS drugDuowell A Plus Tablet 40/20/10/5mg2022-05-20
    Drug · Prescription · Approval202202139
  • MFDS drugDuowell A Plus Tablet 40/10/10/5mg2022-05-20
    Drug · Prescription · Approval202202140
  • MFDSImplant, surgical, guide for medical use2022-05-09
    Product approval · Class 2수인 22-4240 호
  • MFDS drugSenseday-Q Tablet2021-09-24
    Drug · OTC · Notification202106628
  • MFDS drugDuowell Plus Tablet 80/20/10mg2021-09-24
    Drug · Prescription · Approval202106630
  • MFDS drugDuowell Plus Tablet 80/10/10mg2021-09-24
    Drug · Prescription · Approval202106631
  • MFDS drugDuowell Plus Tablet 80/5/10mg2021-09-24
    Drug · Prescription · Approval202106632
  • MFDS drugDuowell Plus Tablet 40/20/10mg2021-09-24
    Drug · Prescription · Approval202106633
  • MFDS drugDuowell Plus Tablet 40/10/10mg2021-09-24
    Drug · Prescription · Approval202106634
  • MFDS drugDuowell Plus Tablet 40/5/10mg2021-09-24
    Drug · Prescription · Approval202106635
  • MFDS drugRaboni-D Tablet2021-06-16
    Drug · Prescription · Approval202104637
  • MFDS drugMag-B Max Soft Capsule2021-06-04
    Drug · OTC · Notification202104379
  • MFDS drugMegatrue Max Tablet2021-05-03
    Drug · OTC · Notification202103624
  • MFDS drugYuhan Metformin XR Tablet 1000mg2021-04-13
    Drug · Prescription · Approval202103063
  • MFDS drugYuhan Rivaroxaban Tablet 20mg2021-04-13
    Drug · Prescription · Approval202103076
  • MFDS drugYuhan Rivaroxaban Tablet 15mg2021-04-13
    Drug · Prescription · Approval202103077
  • MFDS drugYuhan Rivaroxaban Tablet 10mg2021-04-13
    Drug · Prescription · Approval202103078
  • MFDSimplant, endosseous, hand instrument2021-03-29
    Product approval · Class 1수신 21-519 호

Showing the 80 most recent of 593 records.

Clinical trials

data.go.kr

101 MFDS clinical trial authorisations · 2012–2026 (Phase 1 40 · Bioequivalence 36 · Phase 3 11 · Phase 2 7 · Phase 1/2 4)

  • Phase 1YH257242026-05-29

    1 trial site

  • BioequivalenceYHP2508C2026-04-17

    1 trial site

  • BioequivalenceYHP25112026-02-24

    1 trial site

  • Phase 1AD-1162026-02-09

    1 trial site

  • Phase 2YH353242025-10-14

    12 trial sites

  • BioequivalenceYHP24062025-09-19

    1 trial site

  • Phase 1AD-1162025-08-22

    1 trial site

  • Phase 3YHP24012025-07-09

    11 trial sites

  • Phase 1/2YH323642025-04-07

    4 trial sites

  • Bioequivalence유한세파클러건조시럽(YHP2407)2025-03-11

    1 trial site

  • BioequivalenceYHP24062025-02-19

    1 trial site

  • BioequivalenceYHP22052024-11-13

    1 trial site

Show 68 more
  • Phase 3YHP2005(NTCB01)2024-09-09

    10 trial sites

  • Phase 3NTCB02-012024-09-09

    8 trial sites

  • Phase 1YHP24012024-08-09

    2 trial sites

  • Phase 1YH359952024-06-28

    1 trial site

  • Phase 1/2YH429462024-06-12

    7 trial sites

  • BioequivalenceYHP23052024-05-21

    1 trial site

  • BioequivalenceYHP22052024-03-26

    1 trial site

  • Phase 1AD-1142023-07-06

    1 trial site

  • Phase 1AD-1142023-06-16

    1 trial site

  • Phase 1YH353242023-05-22

    11 trial sites

  • Extension레이저티닙 (YH25448)2023-01-04

    12 trial sites

  • Phase 1bYH353242022-08-16

    9 trial sites

  • Phase 1/2YH323672022-06-21

    13 trial sites

  • BioequivalenceYHP17032022-04-07

    2 trial sites

  • BioequivalenceYHP17032021-12-13

    2 trial sites

  • Bioequivalence렉라자정80밀리그램 (레이저티닙, YH25448)2021-09-29

    1 trial site

  • Phase 1YH353242021-07-16

    5 trial sites

  • Phase 1YHD1119정2021-06-16

    3 trial sites

  • BioequivalenceYHP18112020-06-04

    1 trial site

  • BioequivalenceYHD1119정 300mg2020-06-02

    2 trial sites

  • BioequivalenceYHP1807정 20밀리그램2020-05-21

    2 trial sites

  • BioequivalenceYHP17032020-02-18

    2 trial sites

  • BioequivalenceYHP17032020-02-18

    2 trial sites

  • BioequivalenceYHP19062020-02-11

    2 trial sites

  • Phase 3레이저티닙 (YH25448)2019-12-11

    26 trial sites

  • BioequivalenceYHP1807정 20밀리그램2019-11-18

    2 trial sites

  • BioequivalenceYHP1807 2.5밀리그램2019-11-18

    2 trial sites

  • Phase 1YHP19032019-11-11

    1 trial site

  • BioequivalenceAD-1032019-08-09

    2 trial sites

  • BioequivalenceYHP18042019-06-10

    2 trial sites

  • BioequivalenceYHP18042019-05-31

    2 trial sites

  • BioequivalenceYHP18052018-10-29

    2 trial sites

  • BioequivalenceYHP18042018-10-19

    2 trial sites

  • Bioequivalence로수바미브정10/5밀리그램2018-10-01

    2 trial sites

  • Bioequivalence로수바미브정10/20밀리그램2018-10-01

    2 trial sites

  • Phase 1YH221622018-08-14

    1 trial site

  • Phase 1레이저티닙 (YH25448)2018-05-25

    1 trial site

  • Phase 1YHP16042018-04-20

    1 trial site

  • BioequivalenceYHP17032018-01-24

    2 trial sites

  • Phase 1YHP16042017-12-14

    1 trial site

  • Phase 1YHP16042017-11-06

    1 trial site

  • Phase 1YH147552017-07-19

    1 trial site

  • BioequivalenceYHP1606캡슐60mg(덱스란소프라졸)2017-06-14

    2 trial sites

  • Phase 1YH261362017-06-14

    1 trial site

  • Phase 1YHP16042017-03-28

    1 trial site

  • Phase 1YHD11192017-03-27

    1 trial site

  • Phase 3YHP16042017-01-04

    28 trial sites

  • Phase 1/2레이저티닙 (YH25448)2016-12-23

    16 trial sites

  • Phase 3YHD11192016-11-25

    31 trial sites

  • Bioequivalence오셀비어현탁용분말 6mg/mL2016-11-07

    2 trial sites

  • Phase 3YHP17012016-10-24

    15 trial sites

  • Phase 1YHP16042016-08-12

    1 trial site

  • Phase 2YH1177, YH1177-D2016-06-03

    20 trial sites

  • Phase 1YHD11192016-05-31

    1 trial site

  • BioequivalenceYH12552016-03-24

    2 trial sites

  • Phase 2YH235372016-02-29

    12 trial sites

  • Phase 1YHD11192016-01-12

    2 trial sites

  • Bioequivalence아나그렐리드캡슐0.5mg(아나그렐리드염산염)(가칭)2015-12-03

    2 trial sites

  • Phase 3YH221622015-11-09

    35 trial sites

  • Phase 1YH221892015-11-09

    2 trial sites

  • Phase 2YH235372015-10-01

    10 trial sites

  • Phase 3YH147552015-09-02

    23 trial sites

  • Phase 2YH128522015-08-21

    32 trial sites

  • Phase 1YH128522015-07-08

    1 trial site

  • Phase 1YH221622015-06-17

    2 trial sites

  • Bioequivalence알포아티린정(가칭)(콜린알포세레이트)2014-12-23

    2 trial sites

  • Phase 1YH232342014-10-24

    1 trial site

  • Bioequivalence타다포스정20mg(타다라필)2014-10-01

    2 trial sites

Showing the 80 most recent of 101 records.

R&D and key agreements

Source: DART corporate disclosure

제2, 제3의 렉라자 파이프라인 · Priority pipeline programs aimed at developing the next Leclaza-level innovative drugs are progressing as planned.

Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SHINHUNG CO.,LTD25 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

DENTIS CO.,LTD24 shared

Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.

DIO Corporation20 shared

DIO Corporation, established in 1988 and listed on KOSDAQ in 2000, manufactures and sells dental implants.

CG MedTech Co.,Ltd.14 shared

Founded in 1997 and KOSDAQ-listed in 2015, CG MedTech makes orthopedic medical devices and also operates an electric energy business.

Corentec Co., Ltd.14 shared

Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.

Alpha AI Co.,Ltd.13 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

MEDYSSEY CO.,LTD10 shared

Manufactures spinal implants and metal 3D-printed patient-specific implants, exporting to over 25 countries.

CELLUMED CO., LTD.7 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

Organ Eco Tech Co.,Ltd.7 shared

Organ Eco Tech, founded in 2006 and KONEX-listed in 2016, manufactures spinal implants.

WSI Co., Ltd.7 shared

Founded and KOSDAQ-listed in 2018, WSI distributes spine/joint devices and has expanded into medical robots and pharma via subsidiaries.

JMT CO.,Ltd.6 shared

Provides EMS and SMT manufacturing services for TFT-LCD and OLED panel driver PBAs.

L&K BIOMED CO., LTD.6 shared

Spinal implant device maker founded 2008, listed on KOSDAQ 2016; produces Cervical and Thoraco Lumbar Cage, Screw, and Plate products.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition